Year
Edition number
№4 / 2024
Current events
Resolution of the V All-Russian scientific and practical conference with international participation «Modern immunoprophylaxis: challenges,opportunities, prospects» (Moscow, October 10–11, 2024)
108-109
Exchange of experience
Zubkova T.G., Pozdnyakova M.G., Agafyina A.S., Rodygin S.A., Popova I.A.
Efficacy oF «Galavit®» in combination therapy of ari аnd influenza in adult patients: results of a multicenter randomized double-blind placebo-controlled study101-107
Reviews and lectures
Tereshkin N.A., Makashova V.V., Ponezheva Z.B., Omarova Kh.G.
Biomarkers of liver fibrosis and cirrhosis in chronic hepatitis C. Clinical and pathophysiological aspects94-100
Shkarin V.V., Kovalishena O.V., Sergeeva A.V.
Orphan diseases of infectious genesis84-93
Original investigations
Breneva N.V., Budaeva S.E., Ostapenko N.A., Belyaeva L.I., Faizullina N.M., Kozlova I.I., Nechaeva E.E., Kudryavtseva I.V., Solovieva M.G., Balakhonov S.V.
Spread of leptospirosis in non-endemic territory77-83
Serdyuk N.S., Zhilchenko E.B., Kuznetsova I.V., Zharinova N.V., Kovalev D.A., Shapakov N.A., Khachaturova A.A., Belozerova O.N., Karapetyan M.G.
Characteristics of Brucella melitensis strains isolated in different regions of the Russian Federation70-76
Savchenko A.A., Tikhonova E.P., Anisimova A.A., Kudryavtsev I.V., Anisimova E.N., Borisov A.G.
Relationship between NKT cell phenotype and liver fibrosis degree in patients with chronic hepatitis C before and after treatment60-69
Khristoforova E.L., Bogorodskaya E.M., Nozdrevatykh I.V., Kotova E.A.
Risk of COVID-19 infection in medical workers of anti-tuberculosis facilities infected with M. tuberculosis55-59
Koltsova I.V., Domonova E.A., Silveystrova O.Yu., Kisteneva L.B., Lyalina E.V.
Modern approaches to the prevention of varicella in newborns at risk of perinatal infection47-54
Belyaeva V.V., Kozyrina N.V., Sokolova E.V., Kulabukhova E.I., Kuimova U.A., Goliusova M.D.
Attitude towards the disease as a risk marker of violation of adherence in HIV-infected patients41-46
Shakhgildyan V.I., Yadrikhinskaya M.S., Domonova E.A., Orlovsky A.A., Kanestri V.G., Yarovaya E.B.
Quantitative determination of Epstein–Barr virus DNA in biological materials and EBV-related lung damage in HIV-infected patients33-40
Epidemic situation
Mamchits L.P., Tumash O.L.
Conуugacy of epidemic processes of leptospirosis and HFRS on the example of Gomel Region26-32
Khokhlachkina I.A., Ignatkova A.S., Kozlova T.V., Chekanova T.A.
Epidemiological and epizootological situation of tick-borne infections in the Tula Region17-25
Soliev A.A., Sattorov S.S., Odinazoda M.E., Usmanova G.M.
Epidemiological surveillance of HIV cases in the Republic of Tajikistan13-16
Sizikova T.E., Karulina N.V., Saifulina N.A., Lebedev V.N., Borisevich S.V.
Some еpidemic indicators of increase in COVID-19 incidence in Russia in 2020–20236-12
